In the latest trading session,, 0.76 million Atyr Pharma Inc (NASDAQ:ATYR) shares changed hands as the company’s beta touched 0.89. With the company’s most recent per share price at $5.14 changing hands around $0.11 or 2.29% at last look, the market valuation stands at $457.93M. ATYR’s current price is a discount, trading about -16.34% off its 52-week high of $5.98. The share price had its 52-week low at $1.48, which suggests the last value was 71.21% up since then. When we look at Atyr Pharma Inc’s average trading volume, we note the 10-day average is 4.02 million shares, with the 3-month average coming to 2.04 million.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Instantly ATYR is in green as seen in intraday trades today. With action 3.31%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 236.27%, with the 5-day performance at 3.31% in the green. However, in the 30-day time frame, Atyr Pharma Inc (NASDAQ:ATYR) is 20.92% up. Looking at the short shares, we see there were 13.64 million shares sold at short interest cover period of 6.12 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.28%. The 2025 estimates are for Atyr Pharma Inc earnings to increase by 28.86%.

ATYR Dividends

Atyr Pharma Inc is expected to release its next quarterly earnings report on 2025-May-07.

Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.23% of Atyr Pharma Inc shares while 69.63% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 71.22%.